TAC1 and hypersensitivity reaction disease: Using pharmacological (substance P receptor inhibitor, aprepitant) and genetic approaches (substance P-KO mice), we found that substance P did not affect avoidance behaviour to OVA after allergic sensitization (Extended Data Fig. 7b,d).